Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Shares Issued (2023 - 2025)

Neuraxis' Shares Issued history spans 3 years, with the latest figure at -$4.0 million for Q3 2025.

  • For Q3 2025, Shares Issued changed N/A year-over-year to -$4.0 million; the TTM value through Sep 2025 reached -$3.9 million, up 25.72%, while the annual FY2024 figure was $26180.0, 87.48% down from the prior year.
  • Shares Issued for Q3 2025 was -$4.0 million at Neuraxis, down from $29.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $200250.0 in Q1 2024 and bottomed at -$5.3 million in Q4 2023.
  • The 3-year median for Shares Issued is -$87020.5 (2024), against an average of -$1.5 million.
  • The largest YoY upside for Shares Issued was 100.02% in 2025 against a maximum downside of 43.82% in 2025.
  • A 3-year view of Shares Issued shows it stood at -$5.3 million in 2023, then skyrocketed by 96.69% to -$174070.0 in 2024, then crashed by 2196.21% to -$4.0 million in 2025.
  • Per Business Quant, the three most recent readings for NRXS's Shares Issued are -$4.0 million (Q3 2025), $29.0 (Q2 2025), and $112493.0 (Q1 2025).